Safety Alert Or Field Safety Notices for Testicular implants and inflatable vaginal stents

According to Medicines and Healthcare products Regulatory Agency, this safety alert or field safety notices involved a device in United Kingdom that was produced by Coloplast A/S.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Safety alert / Field Safety Notice
  • Date
    2015-10-15
  • Event Date Posted
    2015-10-15
  • Event Country
  • Event Source
    MHRA
  • Event Source URL
  • Notes / Alerts
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • Extra notes in the data
    The German medical device regulatory authority informed MHRA on Friday 18 September 2015 that a German notified body had temporarily suspended the marketing and distribution of all medical devices manufactured by Silimed lndustria de lmplantes Ltda.A recent inspection of the manufacturing facility by the notified body identified particles on the surface of some devices. See MHRA’s alert MDA/2015/034 published on Friday 25 September 2015.It has subsequently been established that testicular implants and vaginal stents manufactured by Coloplast A/S are made under sub-contract by Silimed lndustria de lmplantes Ltda and so are also affected by the temporary suspension.MHRA is investigating in collaboration with other European regulators and recommends that none of these devices should be implanted until further advice is issued.The manufacturer issued a field safety notice (FSN) dated 9 October 2015.
  • Reason
    Manufactured by coloplast a/s – temporary suspension of the ce certificate due to particles found on some implantable devices made by their subcontractor silimed lndustria de lmplantes ltda - mda/2015/036.
  • Action
    Do not implant affected devices Quarantine devices Await further advice from the manufacturer and/or MHRA If patients enquire they can be reassured that this situation is being investigated as a matter of priority with our European counterparts to decide on further action. However, if they would like to be kept up to date they can register for email updates and they will be kept informed.

Device

  • Model / Serial
  • Product Description
    All batches of the following devices manufactured by Coloplast A/S are affected:Testicular implants, product codes: PR3001, PR3002, PR3003, PR3004, PR3005Vaginal stents – inflatable, product codes: VS3020, VS3022, VS3024, VS3026
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Coloplast A/S Tina Gotschalk Holtedam 1 Humlebæk 3050 DenmarkTelephone: +45 4911 3339Email: vigilance@coloplast.com
  • Manufacturer Parent Company (2017)
  • Source
    MHRA